Last $172.26 USD
Change Today -5.66 / -3.18%
Volume 2.9M
ILMN On Other Exchanges
As of 8:10 PM 09/19/14 All times are local (Market data is delayed by at least 15 minutes).

Transactions by ILLUMINA INC (ILMN) in the last 6 months

Announced 07/16/14
Myraqa, Inc.

Illumina Inc. (NasdaqGS:ILMN) acquired Myraqa from Mya Thomae on July 16, 2014. As part of Illumina, Myraqa's team will continue to report to Mya Thomae. Mya Thomae will report to Rick Klausner, Chief Medical Officer of Illumina, as the Vice President of Regulatory Affairs.

ILMN's price was unchanged after the transaction was announced on 07/16/14.
Investor / Buyer
Illumina Inc.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ILMN:US $172.26 USD -5.66

ILMN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Alexion Pharmaceuticals Inc $161.44 USD -0.12
Avago Technologies Ltd $89.10 USD -0.42
Sigma-Aldrich Corp $102.37 USD -0.93
UCB SA €68.12 EUR -0.15
Vertex Pharmaceuticals Inc $103.75 USD +6.40
View Industry Companies

Industry Analysis


Industry Average

Valuation ILMN Industry Range
Price/Earnings 100.0x
Price/Sales 14.0x
Price/Book 22.2x
Price/Cash Flow 93.7x
TEV/Sales 13.4x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ILLUMINA INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at